Efficacy and Safety of ALT-801 in the Treatment of Obesity

Clinical trial NCT05295875 · COMPLETED

Trial details

NCT number: NCT05295875
Sponsor: Altimmune, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Obesity/Overweight

Start date: 2022-03-31
Primary completion: 2023-09-28
Enrollment: 391

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.